• PDF / 169,251 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 59 Downloads / 127 Views

DOWNLOAD

REPORT

---

1 S

Pneumonitis: case report In a retrospectively study (between March 2013 and December 2017) involving 44 patients, one patient [age and sex not stated] was described, who developed pneumonitis during treatment with carboplatin and paclitaxel for non-squamous non-small cell lung cancer (non-squamous NSCLC). The patient, who had non-squamous NSCLC, received chemotherapy regimen with carboplatin on day 1 and paclitaxel (albuminbound paclitaxel-nab-PTX) on days 1, 8 and 15 in a 21 day cycle [routes and dosages not stated]. However, the patient developed ≥ grade 3 pneumonitis [duration of treatments to reaction onset and outcome not stated]. Subsequently, the patient died of unknown reason. Tanaka M, et al. The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients. 803500652 Respiratory Investigation 58: 269-274, No. 4, Jul 2020. Available from: URL: http://doi.org/10.1016/j.resinv.2019.12.008

0114-9954/20/1821-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 12 Sep 2020 No. 1821